Clinical Trial Detail

NCT ID NCT01164228
Title Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eastern Cooperative Oncology Group
Indications

renal cell carcinoma

Therapies

Sunitinib

Gemcitabine

Age Groups: senior adult

No variant requirements are available.